EFM
E Fund Management Portfolio holdings
AUM
$2.1B
This Quarter Return
+12.44%
1 Year Return
+23.31%
3 Year Return
+155.42%
5 Year Return
–
10 Year Return
–
AUM
$1.31B
AUM Growth
+$1.31B
(+3.9%)
Cap. Flow
-$33.1M
Cap. Flow
% of AUM
-2.52%
Top 10 Holdings %
Top 10 Hldgs %
65.03%
Holding
329
New
20
Increased
146
Reduced
123
Closed
37
Top Buys
| 1 |
KLA
KLAC
|
$9.71M |
| 2 |
Pinduoduo
PDD
|
$8.56M |
| 3 |
iShares Gold Trust
IAU
|
$3.24M |
| 4 |
SPDR Gold MiniShares Trust
GLDM
|
$3.14M |
| 5 |
iShares MSCI Global Gold Miners ETF
RING
|
$3.08M |
Top Sells
| 1 |
Grab
GRAB
|
$40.9M |
| 2 |
NVIDIA
NVDA
|
$7.48M |
| 3 |
Microsoft
MSFT
|
$5.75M |
| 4 |
STAAR Surgical
STAA
|
$4.82M |
| 5 |
Sea Limited
SE
|
$3.38M |
Sector Composition
| 1 | Consumer Discretionary | 45.37% |
| 2 | Technology | 25.37% |
| 3 | Communication Services | 8.93% |
| 4 | Healthcare | 6.43% |
| 5 | Real Estate | 6.06% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
251
Boston Scientific
BSX
$156B
| $207K | 0.02% |
3,924
-302
| -7% | -$15.9K |
|
252
Geron
GERN
$893M
| $207K | 0.02% |
97,708
+26,473
| +37% | +$56.1K |
|
253
Zentalis Pharmaceuticals
ZNTL
$122M
| $207K | 0.02% |
10,307
-3,185
| -24% | -$64K |
|
254
Viridian Therapeutics
VRDN
$1.5B
| $206K | 0.02% |
13,437
+315
| +2% | +$4.83K |
|
|
WBA
255
DELISTED
Walgreens Boots Alliance
WBA
| $206K | 0.02% |
9,263
+1,412
| +18% | +$31.4K |
|
|
BLUE
256
DELISTED
bluebird bio
BLUE
| $204K | 0.02% |
66,978
-21,612
| -24% | -$65.8K |
|
257
Hewlett Packard
HPE
$29.6B
| $204K | 0.02% |
11,726
-914
| -7% | -$15.9K |
|
258
Becton Dickinson
BDX
$55.3B
| $203K | 0.02% |
784
-65
| -8% | -$16.8K |
|
259
HP
HPQ
$26.7B
| $202K | 0.02% |
7,878
-589
| -7% | -$15.1K |
|
260
Monolithic Power Systems
MPWR
$40B
| $201K | 0.02% |
435
-8
| -2% | -$3.7K |
|
261
Editas Medicine
EDIT
$231M
| $199K | 0.02% |
25,455
-5,468
| -18% | -$42.7K |
|
|
VERV
262
DELISTED
Verve Therapeutics
VERV
| $191K | 0.01% |
14,397
+1,499
| +12% | +$19.9K |
|
263
MannKind Corp
MNKD
$1.41B
| $182K | 0.01% |
43,955
-19,726
| -31% | -$81.7K |
|
264
Myriad Genetics
MYGN
$593M
| $172K | 0.01% |
10,709
+159
| +2% | +$2.55K |
|
265
Coherus Oncology, Inc. Common Stock
CHRS
$135M
| $168K | 0.01% |
+45,010
| New | +$168K |
|
266
AT&T
T
$209B
| $168K | 0.01% |
11,172
-767
| -6% | -$11.5K |
|
267
Travere Therapeutics
TVTX
$1.56B
| $166K | 0.01% |
18,596
-8,198
| -31% | -$73.2K |
|
268
Biomea Fusion
BMEA
$116M
| $165K | 0.01% |
+12,010
| New | +$165K |
|
269
SiriusXM
SIRI
$7.96B
| $164K | 0.01% |
36,247
+6,521
| +22% | +$29.5K |
|
270
Relay Therapeutics
RLAY
$619M
| $163K | 0.01% |
19,403
-14,305
| -42% | -$120K |
|
271
Day One Biopharmaceuticals
DAWN
$769M
| $149K | 0.01% |
12,176
-3,465
| -22% | -$42.4K |
|
272
uniQure
QURE
$896M
| $135K | 0.01% |
20,075
+9,422
| +88% | +$63.4K |
|
273
Allogene Therapeutics
ALLO
$251M
| $128K | 0.01% |
40,325
-736
| -2% | -$2.34K |
|
274
Caribou Biosciences
CRBU
$174M
| $125K | 0.01% |
+26,065
| New | +$125K |
|
275
Lucid Motors
LCID
$6.08B
| $120K | 0.01% |
21,439
+7,344
| +52% | +$41.1K |
|